Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?

Transcatheter aortic valve replacement (TAVR) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis at increased surgical risk. Antithrombotic therapy after TAVR aims to prevent transcatheter heart valve (THV) thrombosis, in which two different enti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosseel, Liesbeth, De Backer, Ole, Søndergaard, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482296/
https://www.ncbi.nlm.nih.gov/pubmed/31058168
http://dx.doi.org/10.3389/fcvm.2019.00044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482296/
https://www.ncbi.nlm.nih.gov/pubmed/31058168
http://dx.doi.org/10.3389/fcvm.2019.00044

Ejemplares similares